Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
Kyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, Miyeun Han, Dong Won Lee, Hyuk-Sang Kwon, , ,
Kidney Res Clin Pract. 2020;39(1):32-39.   Published online 2020 Mar 31     DOI: https://doi.org/10.23876/j.krcp.20.012
Citations to this article as recorded by Crossref logo
Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
Hyo Jin Kim, Sang Soo Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2022; 37(3): 502.     CrossRef
Insulin resistance in children
Francesca Mainieri, Veronica Maria Tagi, Francesco Chiarelli
Current Opinion in Pediatrics.2022; 34(4): 400.     CrossRef
Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside
Sungjin Chung, Gheun-Ho Kim
Life.2021; 11(5): 389.     CrossRef
Advantages of Metformin Therapy for the Prevention and Mitigation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease: A Real-Word Evidence From Large-Scale Cohort
Soie Kwon, Jeong Hyun Ha, Dong Ki Kim, Yon Su Kim, Chun Soo Lim, Hak Chang, Jung Pyo Lee, Ji-Ung Park
SSRN Electronic Journal .2021;[Epub]     CrossRef
Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
Min Ho Kim, Hyung Jung Oh, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim, Dong-Ryeol Ryu
Kidney Research and Clinical Practice.2021; 40(4): 660.     CrossRef
KRCP's past and future path
Tae-Hyun Yoo
Kidney Research and Clinical Practice.2020; 39(3): 233.     CrossRef